Skip to main content
Terug
Watch Compare

AGENUS INC

Datakwaliteit: 100%
AGEN
Nasdaq Manufacturing Chemicals
€ 3,96
▼ € 0,49 (-11,01%)
Marktkapitalisatie: 171,06 M
Prijs
€ 4,46
Marktkapitalisatie
171,06 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -21,17% annually over 5 years
Negative free cash flow of -77,20 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 31,54%
Capital efficient — spends only 0,01% of revenue on capex

Groei

Revenue Growth (5Y)
-21,17%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)10,37%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-2,70%
Op. Margin-17,66%

Veiligheid

Debt / Equity
N/A
Current Ratio0,47
Interest Coverage-0,36

Waardering

PE (TTM)
-55,49
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -55,5 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -2,7 -41,5
Rev Growth 5Y % -21,2 1,8
D/E — 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 3,96
+291.4%
Koersdoel
€ 15,50
€ 8,00
€ 15,50
€ 23,00
Vooruitzicht
Forward K/W -1,72
Forward WPA -€ 2,30
WPA Groei (sch.) -560,0%
Omzet Sch. 131,20 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 2,30
-€ 2,30 – -€ 2,30
 131,20 M 1
FY2026 € 0,50
€ 0,50 – € 0,50
 232,90 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 1,30 € 0,68 +152,4%
Q32025 € 2,20 -€ 1,16 -152,9%
Q22025 € 1,35 -€ 1,00 -173,9%
Q12025 -€ 1,98 -€ 1,03 +48,0%

ETFs Holding This Stock

CNCR CNCR
0,83% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 10,37% Revenue Growth (3Y) -14,53%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -21,17% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 114,20 M Net Income (TTM) -3,08 M
ROE N/A ROA -1,47%
Gross Margin N/A Operating Margin -17,66%
Net Margin -2,70% Free Cash Flow (TTM) -77,20 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,47
Interest Coverage -0,36 Asset Turnover 0,54
Working Capital -153,18 M Tangible Book Value -301,35 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -55,49 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,50
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -45,13%
Market Cap 171,06 M Enterprise Value 201,82 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share 2,97
FCF / Share -2,01 OCF / Share -2,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,01% FCF Conversion 2504,09%
SBC-Adj. FCF -92,04 M Growth Momentum 31,54

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 114,20 M 103,46 M 156,31 M 98,02 M 295,67 M
Net Income -3,08 M -232,27 M -257,44 M -230,66 M -28,72 M
EPS (Diluted) 0,00 -10,59 -0,69 -0,78 —
Gross Profit — — — — —
Operating Income -20,17 M -120,48 M -159,55 M -179,43 M 25,75 M
EBITDA — — — — —
R&D Expenses 79,34 M 155,53 M 234,57 M 186,69 M 178,61 M
SG&A Expenses — — — — —
D&A 10,00 M 13,34 M 13,59 M 6,95 M 6,79 M
Interest Expense 55,62 M 120,42 M — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 226,80 M 226,27 M 313,91 M 413,56 M 465,96 M
Total Liabilities — — — — —
Shareholders' Equity -271,11 M -326,38 M -160,33 M -61,28 M 34,44 M
Total Debt 44,66 M 33,17 M 12,77 M 12,58 M 12,82 M
Cash & Equivalents 3,00 M 40,44 M 76,11 M 178,67 M 291,93 M
Current Assets 133,44 M 45,57 M 112,42 M 213,12 M 331,97 M
Current Liabilities 323,49 M 221,40 M 255,90 M 188,95 M 156,94 M